<DOC>
	<DOCNO>NCT01505504</DOCNO>
	<brief_summary>Weight loss frequent problem associate Alzheimers disease ( AD ) . Mirtazapine weight loss frequent side effect . The aim retrospective study check whether mirtazapine 30 mg ( daily ) counteract weight loss patient AD mixed dementia ( AD + vascular ) .</brief_summary>
	<brief_title>Mirtazapine Alzheimer-associated Weight Loss</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<criteria>AD mixed dementia document weight loss mirtazapine 30 mg explicitly prescribe weight loss treatment compliance cause weight loss intervention weight loss</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>